✦ LIBER ✦

Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results

✍ Scribed by DJ Slamon

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibitory effects of combinations of HE

✍ Pegram, Mark; Hsu, Sheree; Lewis, Gail; Pietras, Richard; Beryt, Malgorzata; Sli 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 255 KB

Advances in the Adjuvant Treatment of HE

✍ Chris Schwab; Joyce A. O'Shaughnessy 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 467 KB

Dose escalation and pharmacokinetic stud

✍ Tokuda, Y; Watanabe, T; Omuro, Y; Ando, M; Katsumata, N; Okumura, A; Ohta, M; Fu 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 331 KB

Evaluation of the new polyclonal rabbit

✍ R. Emig; C. Zeeb; N. Fersis; P. Ruck; H.B.G. Franz; O. Tomé; S.S. Köhler; B. Bül 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 318 KB

Evaluation of HER2 status: For the treat

✍ Shinobu Umemura; Goi Sakamoto; Hironobu Sasano; Hitoshi Tsuda; Futoshi Akiyama; 📂 Article 📅 2001 🏛 Springer Japan 🌐 English ⚖ 998 KB

Phase I clinical trial of the bispecific

✍ Repp, R; van Ojik, H H; Valerius, T; Groenewegen, G; Wieland, G; Oetzel, C; Stoc 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 197 KB